Home › Research › Tau biomarkers
Alzheimer's disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C
Konen FF, Maier HB, Neyazi A, Bleich S, Neumann K, Skripuletz T.. Neurological research and practice, 2023-06-29
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Alzheimer´s disease is considered a neurodegenerative disease and is diagnosed by exclusion, while the detection of specific cerebrospinal fluid (CSF) biomarkers, namely amyloid-beta (Aβ) peptides Aβ1-42 (Aß42), phospho-tau (181P; P-tau), and total-tau (T-tau), has been shown to improve diagnostic accuracy. Recently, a new generation of sample tubes (Sarstedt false-bottom tubes) for the Elecsys CSF immunoassay for the determination of Alzheimer´s disease biomarkers in CSF was introduced, promising better measurability. However, the pre-analytic influencing factors have not yet been sufficiently investigated.
What this study adds
Evidence grade: Low
The record lists 29 participants. This study examined how pre-analytical factors affect Elecsys immunoassay measurements of CSF Aβ42, P-tau and T-tau in 29 patients without an Alzheimer's disease diagnosis, finding stability except with freezing at -80 °C. It concerns laboratory handling of biomarker samples, not treating, curing or preventing the disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Konen, F. F., Maier, H. B., Neyazi, A., Bleich, S., Neumann, K., & Skripuletz, T. (2023). Alzheimer's disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C. Neurological research and practice. https://doi.org/10.1186/s42466-023-00257-5
Vancouver
Konen FF, Maier HB, Neyazi A, Bleich S, Neumann K, Skripuletz T. Alzheimer's disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C. Neurological research and practice. 2023. doi:10.1186/s42466-023-00257-5. PMID: 37381021.
BibTeX
@article{konen2023-37381021,
author = {Konen, F. F. and Maier, H. B. and Neyazi, A. and Bleich, S. and Neumann, K. and Skripuletz, T.},
title = {{Alzheimer's disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C}},
journal = {Neurological research and practice},
year = {2023},
doi = {10.1186/s42466-023-00257-5},
pmid = {37381021},
url = {https://doi.org/10.1186/s42466-023-00257-5}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Recently, a new generation of sample tubes (Sarstedt false-bottom tubes) for the Elecsys CSF immunoassay for the determination of Alzheimer´s disease biomarkers in CSF was introduced, promising better measurability.
- However, the pre-analytic influencing factors have not yet been sufficiently investigated.
- Methods In 29 patients without Alzheimer's disease diagnosis, CSF concentrations of Aß42, P-tau and T-tau were examined in native CSF and after different influencing interventions using the Elecsys immunoassay test method.
- The following influencing factors were analyzed: contamination with blood (10,000 and 20,000 erythrocytes/µl CSF), 14-day storage at 4 °C, blood contamination of CSF and 14-day storage at 4 °C, 14-day freezing at -80 °C in Sarstedt tubes or glass vials, 3-month intermediate storage at -80 °C in glass vials.
Why it matters
This study examined how pre-analytical factors affect Elecsys immunoassay measurements of CSF Aβ42, P-tau and T-tau in 29 patients without an Alzheimer's disease diagnosis, finding stability except with freezing at -80 °C. It concerns laboratory handling of biomarker samples, not treating, curing or preventing the disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants29
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neurological research and practice) |
| Journal's citation record | 0 / 4 | Neurological Research and Practice: journal h-index 37 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 1 / 4 | 29 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.2 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 1 / 6 | Cited 0.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Thomas Skripuletz: h-index 45 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Medizinische Hochschule Hannover: institution h-index 727 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37381021) |
| Free to read | 2 / 2 | Free to read |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1186/s42466-023-00257-5
- PubMed: 37381021
- Original source →
- Free full text: Neurological Research and Practice →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.